I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition

Overview of attention for article published in Frontiers in Pharmacology, April 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,168 followers.

RT @FrontPharmacol: New Research: I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inh…

12 Apr 2023

Reply Repost Favourite

New Research: I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition https://t.co/eHMapf7dmq #pharmacology

12 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.